| 1 | Immunosuppressive therapies for inflammatory bowel disease显示文摘Inflammatory bowel disease(IBD)is comprised of Crohn’s disease and ulcerative colitis,both chronic inflammatory intestinal disorders of unknown etiology characterized by a waxing and waning clinical course.For many years,the drug therapy was limited to sulfasalazine and related aminosalicylates,corticosteroids and antibiotics.Studies suggesting that the pathophysiology of these disorders relates to a disregulated,overactive immune response to indigenous bacteria have led to the increasing importance of immunosuppressive drugs for the therapy of IBD.This review details the mechanisms of action,clinical efficacy,and adverse effects of these agents. | Talia Zenlea Mark A Peppercorn | 2014 | World Journal of Gastroenterology2014，20，12： | 4 |
您所在的机构暂未开通此部分的功能，请联系管理员